Literature DB >> 21800816

The role of prophylactic antibiotics in open fractures in an era of community-acquired methicillin-resistant Staphylococcus aureus.

Carla C Saveli1, Robert W Belknap, Steven J Morgan, Connie S Price.   

Abstract

Infection is a feared complication and a common cause of loss of function following open fractures. Despite the evidence supporting the administration of prophylactic antibiotics after open fractures, data demonstrating the optimal regimen is lacking. We reviewed the data supporting the current prophylaxis recommendations and the changing epidemiology of Staphylococcus aureus, the most common cause of surgical site infection in patients with open fractures. Although widespread emergence of methicillin-resistant Staphylococcus aureus (MRSA) has been described in both hospital and community settings, to date, no studies have addressed the need for prophylaxis against MRSA in patients with open fractures. Until well-designed randomized trials are conducted, we recommend that providers consider selecting antibiotics active against MRSA for open fracture prophylaxis based on the local prevalence of MRSA carriage and individualized risk factors. Copyright 2011, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21800816     DOI: 10.3928/01477447-20110627-25

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  11 in total

Review 1.  [Prevention of infection in the current treatment of open fractures: an evidence-based systematic analysis].

Authors:  S Grote; H Polzer; W C Prall; S Gill; S Shafizadeh; M Banerjee; B Bouillon; H Bäthis
Journal:  Orthopade       Date:  2012-01       Impact factor: 1.087

Review 2.  Current Concepts and Ongoing Research in the Prevention and Treatment of Open Fracture Infections.

Authors:  Geoffrey D Hannigan; Nicholas Pulos; Elizabeth A Grice; Samir Mehta
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-01-01       Impact factor: 4.730

3.  A review of forty five open tibial fractures covered with free flaps. Analysis of complications, microbiology and prognostic factors.

Authors:  Ulrik Kähler Olesen; Rasmus Juul; Christian Torsten Bonde; Claus Moser; Martin McNally; Lisa Toft Jensen; Jens Jørgen Elberg; Henrik Eckardt
Journal:  Int Orthop       Date:  2015-03-08       Impact factor: 3.075

4.  What is the rate of methicillin-resistant Staphylococcus aureus and Gram-negative infections in open fractures?

Authors:  Antonia F Chen; Verena M Schreiber; Wesley Washington; Nalini Rao; Andrew R Evans
Journal:  Clin Orthop Relat Res       Date:  2013-10       Impact factor: 4.176

5.  Controversies in the management of open fractures.

Authors:  O'Brien C L; Menon M; Jomha N M
Journal:  Open Orthop J       Date:  2014-06-27

6.  Open fractures of the lower extremity: Current management and clinical outcomes.

Authors:  Abdel Rahim Elniel; Peter V Giannoudis
Journal:  EFORT Open Rev       Date:  2018-05-21

7.  The Novel Role of Healing from Bacterial Infections of Lower Limb Open Fractures by X-Ray Exposure.

Authors:  Ali A Mahdi; Tuqa S Al-Salmani; Mustafa M Al-Qaisi
Journal:  Int J Microbiol       Date:  2020-03-19

8.  Compliance with the Eastern Association for the Surgery of Trauma guidelines for prophylactic antibiotics after open extremity fracture.

Authors:  Cassie A Barton; Wesley D McMillian; Bruce A Crookes; Turner Osler; Craig S Bartlett
Journal:  Int J Crit Illn Inj Sci       Date:  2012-05

9.  Predebridement wound culture in open fractures does not predict postoperative wound infection: A pilot study.

Authors:  Reddy Lingaraj; John Ashutosh Santoshi; Sheela Devi; Syed Najimudeen; James J Gnanadoss; Rengasamy Kanagasabai; Reba Kanungo
Journal:  J Nat Sci Biol Med       Date:  2015-08

Review 10.  Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases.

Authors:  Lucia Lee; Kate Samardzic; Michael Wallach; Lyn R Frumkin; Daria Mochly-Rosen
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.